AQR Capital Management’s NRC Health Common Stock NRC Stock Holding History

AQR Capital Management’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.64M	Sell	122,206 -49,641	-29%	-$922K	﹤0.01%	2437
2026 Q1	$2.92M	Sell	171,847 -44,929	-21%	-$764K	﹤0.01%	2099
2025 Q4	$4.07M	Sell	216,776 -49,049	-18%	-$740K	﹤0.01%	1698
2025 Q3	$3.4M	Buy	265,825 +64,429	+32%	+$966K	﹤0.01%	1675
2025 Q2	$3.38M	Buy	201,396 +93,262	+86%	+$1.26M	﹤0.01%	1487
2025 Q1	$1.38M	Buy	108,134 +67,882	+169%	+$1.09M	﹤0.01%	1822
2024 Q4	$710K	Buy	40,252 +17,217	+75%	+$327K	﹤0.01%	2073
2024 Q3	$527K	Sell	23,035 -5,901	-20%	-$133K	﹤0.01%	2152
2024 Q2	$664K	Buy	28,936 +4,601	+19%	+$142K	﹤0.01%	1929
2024 Q1	$964K	Buy	24,335 +12,097	+99%	+$478K	﹤0.01%	1708
2023 Q4	$484K	Sell	12,238 -17,493	-59%	-$732K	﹤0.01%	1894
2023 Q3	$1.32M	Buy	29,731 +3,950	+15%	+$172K	﹤0.01%	1501
2023 Q2	$1.12M	Sell	25,781 -11,421	-31%	-$502K	﹤0.01%	1503
2023 Q1	$1.62M	Buy	37,202 +6,086	+20%	+$269K	﹤0.01%	1335
2022 Q4	$1.16M	Buy	31,116 +3,223	+12%	+$125K	﹤0.01%	1507
2022 Q3	$1.11M	Sell	27,893 -11,255	-29%	-$417K	﹤0.01%	1472
2022 Q2	$1.5M	Buy	39,148 +5,054	+15%	+$183K	﹤0.01%	1243
2022 Q1	$1.35M	Buy	34,094 +21,894	+179%	+$857K	﹤0.01%	1390
2021 Q4	$507K	Sell	12,200 -1,206	-9%	-$52.4K	﹤0.01%	1828
2021 Q3	$565K	Sell	13,406 -13	-0.1%	-$655	﹤0.01%	1820
2021 Q2	$616K	Sell	13,419 -1,087	-7%	-$51.7K	﹤0.01%	1814
2021 Q1	$679K	Sell	14,506 -17,844	-55%	-$867K	﹤0.01%	1720
2020 Q4	$1.38M	Sell	32,350 -20,618	-39%	-$1.06M	﹤0.01%	1351
2020 Q3	$2.61M	Sell	52,968 -29,798	-36%	-$1.65M	﹤0.01%	993
2020 Q2	$4.82M	Sell	82,766 -5,412	-6%	-$286K	0.01%	802
2020 Q1	$4.01M	Buy	88,178 +53,277	+153%	+$3.2M	0.01%	850
2019 Q4	$2.3M	Buy	34,901 +8,927	+34%	+$546K	﹤0.01%	1216
2019 Q3	$1.5M	Buy	+25,974	New	+$1.61M	﹤0.01%	1390

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management's NRC Position: Q2 2026 in Review

AQR Capital Management reduced its NRC Health Common Stock (NRC) stake by 29% in Q2 2026, selling an estimated $922K and leaving 122,206 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2437.

AQR Capital Management first reported a position in NRC in Q3 2019 and has held it in 28 quarters since. The position peaked at $4.82M in Q2 2020. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

AQR Capital Management held 122,206 shares of NRC Health Common Stock worth $2.64M as of Q2 2026.
AQR Capital Management sold 49,641 NRC Health Common Stock shares in Q2 2026, an estimated $922K.
NRC Health Common Stock made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2437 holding.
AQR Capital Management first reported a position in NRC Health Common Stock in Q3 2019 and has held it in 28 quarters since.
AQR Capital Management's NRC Health Common Stock position peaked at $4.82M in Q2 2020.
124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.